A.R.T. Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-55,298
Closed -$474K 1129
2019
Q4
$474K Buy
55,298
+35,121
+174% +$125K 0.02% 882
2019
Q3
$23K Sell
20,177
-3,700
-15% -$4.3K ﹤0.01% 1364
2019
Q2
$31K Sell
23,877
-4,250
-15% -$5.83K ﹤0.01% 1276
2019
Q1
$40K Buy
28,127
+15,532
+123% +$21.7K ﹤0.01% 1230
2018
Q4
$15K Sell
12,595
-5,812
-32% -$11.3K ﹤0.01% 1260
2018
Q3
$43K Sell
18,407
-11,996
-39% -$29.9K ﹤0.01% 1324
2018
Q2
$83K Sell
30,403
-105,608
-78% -$291K ﹤0.01% 1306
2018
Q1
$372K Sell
136,011
-28,166
-17% -$81.6K 0.01% 1067
2017
Q4
$512K Buy
164,177
+111,080
+209% +$312K 0.02% 884
2017
Q3
$149K Sell
53,097
-119,060
-69% -$321K 0.01% 1181
2017
Q2
$440K Sell
172,157
-200,912
-54% -$547K 0.02% 858
2017
Q1
$1.36M Buy
+373,069
New +$1.58M 0.06% 443
2015
Q4
Sell
-7,250
Closed -$293K 1783
2015
Q3
$293K Sell
7,250
-17,085
-70% -$905K 0.01% 1052
2015
Q2
$1.27M Buy
24,335
+15,546
+177% +$773K 0.04% 633
2015
Q1
$408K Sell
8,789
-9,655
-52% -$501K 0.01% 990
2014
Q4
$827K Buy
+18,444
New +$775K 0.03% 733

Other funds holding ISEE

A.R.T. Advisors's ISEE Position: Q1 2020 in Review

A.R.T. Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2020, closing a stake of 55,298 shares — an estimated $474K sold.

A.R.T. Advisors first reported a position in ISEE in Q4 2014 and held it in 16 quarters. The position peaked at $1.36M in Q1 2017. 75 funds tracked by Wall St. Rank hold ISEE as of Q1 2020.

  • A.R.T. Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 55,298 IVERIC bio, Inc. Common Stock shares in Q1 2020, an estimated $474K.
  • A.R.T. Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 16 quarters.
  • A.R.T. Advisors's IVERIC bio, Inc. Common Stock position peaked at $1.36M in Q1 2017.
  • 75 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.